Vertex Pharmaceuticals Inc (VRTX34)
BOV
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.3B | 2.37B | 2.5B | 2.48B | 2.57B | 2.69B | 2.65B | 2.77B |
| Operating Income | 1.03B | 777.1M | 1.03B | 1.04B | 988.5M | 1.14B | -3.51B | 1.12B |
| Pre Tax Income | 1.08B | 891.5M | 1.16B | 1.18B | 1.1B | 1.28B | -3.39B | 1.22B |
| Net Income | 818.9M | 699.8M | 915.7M | 1.04B | 919.6M | 1.1B | -3.59B | 1.05B |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 994.5M | 778.4M | 1.03B | 1.02B | 963.1M | 1.11B | -3.51B | 1.1B |
| EBITDA | 1.07B | 815.9M | 1.07B | 1.08B | 1.05B | 1.19B | -3.46B | 1.17B |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.7B | 2.49B | 3.05B | 4.16B | 6.21B | 7.58B | 8.99B | 9.92B |
| Operating Income | 9.94M | 123.24M | 635.15M | 1.2B | 2.86B | 2.78B | 4.31B | 3.83B |
| Pre Tax Income | -67.37M | -15.69M | 600.24M | 1.39B | 3.12B | 2.73B | 4.23B | 4.33B |
| Net Income | -112.05M | 263.48M | 2.1B | 1.18B | 2.71B | 2.34B | 3.32B | 3.57B |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.451 | 1.04 | 8.218 | 4.544 | 10.434 | 9.204 | 12.925 | 13.856 |
| EBIT | 9.94M | 41.86M | 634.36M | 1.26B | 2.98B | 2.79B | 4.32B | 3.79B |
| EBITDA | 71.33M | 441.93M | 736.57M | 1.3B | 2.97B | 2.91B | 4.46B | 4.01B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
